UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

______________________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):

January 2, 2018

 

____________________________

 

ChineseInvestors.com, Inc.

(Exact name of registrant as specified in its charter)

 

____________________________

 

 

Indiana   000-54207   35-2089868
(State of Organization)   (Commission File Number)   (I.R.S. Employer Identification Number)
         
227 W. Valley Blvd. #208A, San Gabriel, CA       91776
(Address of principal executive offices)       (Zip Code)

 

(626) 589-2468

(Registrant’s telephone number, including area code)

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

√  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

     

 

 

Item 8.01 Other Events.

 

ChineseInvestors.com,, Inc. announces the results of its online sales in China of its Yantai 1985 brand of baijiu liquor through its CBD Biotechnology Co. Ltd subsidiary .

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits 

 

Exhibit No. Description
   
99.1 Copy of press release that the Company issued on January 2, 2018 announcing the results of its online sales in China of its Yantai 1985 brand of baijiu liquor through its CBD Biotechnology Co. Ltd subsidiary.

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Date: January 2, 2018

 

ChineseInvestors.com, Inc.

 

By: /s/ Wei Wang                                 

Name: Wei Wang

Title: Chief Executive Officer

 

 

 

 

  2